Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 2:2
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)โข Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 3
1 (33.3%)Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer
Phase 2
- Conditions
- Ovarian Cancer
- First Posted Date
- 2004-06-09
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- SmithKline Beecham
- Target Recruit Count
- 40
- Registration Number
- NCT00003733
- Locations
- ๐ฌ๐ง
Charing Cross Hospital, London, England, United Kingdom
๐ฌ๐งMount Vernon Hospital, Northwood, England, United Kingdom
A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis
Phase 3
Completed
- Conditions
- Protozoan InfectionsHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- SmithKline Beecham
- Registration Number
- NCT00002191
- Locations
- ๐บ๐ธ
San Francisco Gen Hosp / Div of GI, San Francisco, California, United States
๐บ๐ธDavies Med Ctr, San Francisco, California, United States
๐บ๐ธGeorge Washington Univ 5-403A, Washington, District of Columbia, United States
Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)
Phase 2
Completed
- Conditions
- HIV InfectionsLeukoencephalopathy, Progressive Multifocal
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- SmithKline Beecham
- Target Recruit Count
- 54
- Registration Number
- NCT00002395
- Locations
- ๐บ๐ธ
Veteran's Administration Hosp / West LA, Los Angeles, California, United States
๐บ๐ธHIV Institute / Davies Med Ctr, San Francisco, California, United States
๐บ๐ธUniv of Miami, Miami, Florida, United States
News
No news found